Medidata Solutions Inc (MDSO) Expected to Post Earnings of $0.36 Per Share
Analysts expect Medidata Solutions Inc (NASDAQ:MDSO) to announce $0.36 earnings per share for the current quarter, according to Zacks. Six analysts have issued estimates for Medidata Solutions’ earnings, with the highest EPS estimate coming in at $0.46 and the lowest estimate coming in at $0.29. Medidata Solutions posted earnings of $0.41 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 12.2%. The company is scheduled to issue its next earnings report on Thursday, February 14th.
According to Zacks, analysts expect that Medidata Solutions will report full-year earnings of $1.63 per share for the current financial year, with EPS estimates ranging from $1.54 to $1.72. For the next fiscal year, analysts expect that the company will report earnings of $1.85 per share, with EPS estimates ranging from $1.67 to $2.00. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that cover Medidata Solutions.
Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings results on Thursday, October 18th. The company reported $0.42 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.36 by $0.06. The company had revenue of $163.41 million during the quarter, compared to the consensus estimate of $162.09 million. Medidata Solutions had a net margin of 8.43% and a return on equity of 10.70%. The firm’s quarterly revenue was up 17.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.33 earnings per share.
Shares of MDSO opened at $70.94 on Friday. The company has a market cap of $4.29 billion, a P/E ratio of 83.46, a PEG ratio of 4.14 and a beta of 1.30. The company has a quick ratio of 2.52, a current ratio of 2.52 and a debt-to-equity ratio of 0.15. Medidata Solutions has a twelve month low of $59.60 and a twelve month high of $88.87.
In related news, EVP Michael I. Otner sold 7,030 shares of Medidata Solutions stock in a transaction on Tuesday, October 23rd. The shares were sold at an average price of $69.40, for a total transaction of $487,882.00. Following the transaction, the executive vice president now owns 62,548 shares in the company, valued at approximately $4,340,831.20. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 4.70% of the stock is currently owned by insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Man Group plc purchased a new position in shares of Medidata Solutions during the 3rd quarter valued at $205,000. Quantbot Technologies LP purchased a new stake in Medidata Solutions in the 3rd quarter worth $229,000. World Asset Management Inc purchased a new stake in Medidata Solutions in the 2nd quarter worth $235,000. Zeke Capital Advisors LLC purchased a new stake in Medidata Solutions in the 2nd quarter worth $239,000. Finally, First Republic Investment Management Inc. purchased a new stake in Medidata Solutions in the 2nd quarter worth $242,000.
About Medidata Solutions
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
See Also: What are earnings reports?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.